ロード中...
Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients
AIM: Dolutegravir is the newest integrase inhibitor approved for HIV treatment and has demonstrated potent antiviral activity in patient populations with a broad range of treatment experience. This analysis aimed to characterize the population pharmacokinetics of dolutegravir in treatment-naive pati...
保存先:
| 出版年: | Br J Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4574835/ https://ncbi.nlm.nih.gov/pubmed/25819132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12639 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|